| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 66.15▲ | 66.19▲ | 66.21▲ | 64.03▲ | 59.97▲ |
| MA10 | 66.09▲ | 66.14▲ | 66.31▼ | 63.22▲ | 56.19▲ |
| MA20 | 66.03▲ | 66.15▲ | 64.90▲ | 60.44▲ | 52.23▲ |
| MA50 | 66.15▲ | 64.02▲ | 63.23▲ | 55.96▲ | 41.31▲ |
| MA100 | 66.27▼ | 63.04▲ | 62.63▲ | 51.55▲ | 35.14▲ |
| MA200 | 65.02▲ | 61.96▲ | 58.76▲ | 43.24▲ | 25.06▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.049▲ | -0.157▼ | 0.059▲ | 0.266▲ | 0.932▲ |
| RSI | 54.126▲ | 57.444▲ | 62.446▲ | 67.906▲ | 76.448▲ |
| STOCH | 82.180▲ | 41.255 | 52.165 | 51.718 | 75.881 |
| WILL %R | -16.102▲ | -62.141 | -30.982 | -21.180▲ | -13.925▲ |
| CCI | 119.021▲ | -32.405 | 41.561 | 132.562▲ | 181.595▲ |
|
Monday, November 10, 2025 08:52 AM
US biopharma BridgeBio Pharma has presented data from the ATTRibute-CM study, showing that acoramidis significantly reduces all-cause mortality (ACM) through month 42 in the overall variant ATTR-CM ...
|
|
Saturday, November 08, 2025 07:51 AM
Simultaneously published in JAMA Cardiology along with moderated posters at AHA, acoramidis demonstrated:59% risk reduction in ACM in the ATTR-CM variant population at Month 42 (p=0.032) compared to ...
|
|
Tuesday, November 04, 2025 05:08 PM
BridgeBio Pharma Inc (BBIO) reports robust sales and promising pipeline developments, despite challenges in operating costs and market competition.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/11/25 | 65.955 | 67.90 | 65.26 | 66.25 | 1,706,404 |
| 11/11/25 | 63.12 | 66.72 | 62.06 | 66.58 | 2,578,836 |
| 10/11/25 | 62.13 | 63.23 | 62.06 | 62.81 | 1,277,168 |
| 07/11/25 | 62.73 | 63.26 | 60.55 | 61.80 | 2,326,272 |
| 06/11/25 | 62.73 | 64.44 | 62.15 | 62.73 | 3,218,860 |
| 05/11/25 | 61.37 | 63.41 | 60.74 | 62.66 | 2,126,014 |
| 04/11/25 | 61.42 | 61.905 | 60.22 | 61.37 | 1,989,302 |
| 03/11/25 | 62.74 | 64.19 | 60.79 | 61.98 | 2,136,951 |
| 31/10/25 | 63.88 | 64.32 | 62.06 | 62.64 | 2,470,591 |
| 30/10/25 | 66.07 | 67.75 | 62.705 | 63.37 | 4,843,434 |
|
|
||||
|
|
||||
|
|